Literature DB >> 29680968

An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects.

Roberto Scicali1, David Rosenbaum2,3, Antonino Di Pino1, Philippe Giral2,4, Philippe Cluzel3,5, Alban Redheuil3,5, Salvatore Piro1, Agata Maria Rabuazzo1, Francesco Purrello6, Eric Bruckert2,4, Antonio Gallo2,3.   

Abstract

AIMS: The association of overweight status and cardiovascular disease is not clear. In this study we aimed to investigate coronary atherosclerotic disease, evaluated as coronary artery calcium score (CACs), in overweight patients with or without abdominal obesity as defined by waist-to-hip ratio (WHR).
METHODS: We enrolled 276 patients aged between 40 and 70 years, with a body mass index of 25-29.9 kg/m2 and at least one cardiovascular risk factor. Exclusion criteria were history of diabetes, cardiovascular or renal disease. Patients were stratified in high WHR (H-WHR) or low WHR (L-WHR) group according to WHR (≥ 0.85 for women and ≥ 0.90 for men) and underwent multi-detector computed tomography for CACs. Mean carotid intima-media thickness (IMT) and plaque presence were equally assessed.
RESULTS: CACs was higher in the H-WHR group compared to L-WHR (9.05 [0.0-83.48] vs 0.0 [0.0-64.7] AU, p < 0.01); the prevalence of CACs > 0 in the H-WHR group was significantly higher than subjects with L-WHR (59.6% vs 38.5%, p < 0.001). Moreover, H-WHR group had higher mean IMT (0.64 [0.56-0.72] vs 0.59 [0.55-0.67] mm, p < 0.05) and higher carotid plaque prevalence (63.7% vs 50.8%, p < 0.05) compared to subjects with L-WHR. Logistic regression showed that H-WHR was associated with presence of CACs and carotid plaque (p < 0.01). In a multiple linear regression, WHR was positively associated with CACs and IMT (p < 0.01).
CONCLUSIONS: H-WHR is a marker of coronary and peripheral atherosclerotic burden in overweight patients.

Entities:  

Keywords:  Cardiovascular risk assessment; Coronary artery calcium score; Intima-media thickness; Overweight; WHR

Mesh:

Year:  2018        PMID: 29680968     DOI: 10.1007/s00592-018-1144-9

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  10 in total

1.  Altered Cortical Brain Structure and Increased Risk for Disease Seen Decades After Perinatal Exposure to Maternal Smoking: A Study of 9000 Adults in the UK Biobank.

Authors:  Lauren E Salminen; Rand R Wilcox; Alyssa H Zhu; Brandalyn C Riedel; Christopher R K Ching; Faisal Rashid; Sophia I Thomopoulos; Arvin Saremi; Marc B Harrison; Anjanibhargavi Ragothaman; Victoria Knight; Christina P Boyle; Sarah E Medland; Paul M Thompson; Neda Jahanshad
Journal:  Cereb Cortex       Date:  2019-12-17       Impact factor: 5.357

2.  Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.

Authors:  Mohammad Muzaffar Mir; Rashid Mir; Mushabab Ayed Abdullah Alghamdi; Javed Iqbal Wani; Zia Ul Sabah; Mohammed Jeelani; Vijaya Marakala; Shahzada Khalid Sohail; Mohamed O'haj; Muffarah Hamid Alharthi; Mohannad Mohammad S Alamri
Journal:  J Pers Med       Date:  2022-05-01

Review 3.  Is Obesity a Risk Factor for Carotid Atherosclerotic Disease?-Opportunistic Review.

Authors:  Joana Ferreira; Pedro Cunha; Alexandre Carneiro; Isabel Vila; Cristina Cunha; Cristina Silva; Adhemar Longatto-Filho; Amílcar Mesquita; Jorge Cotter; Margarida Correia-Neves; Armando Mansilha
Journal:  J Cardiovasc Dev Dis       Date:  2022-05-17

4.  Altered Visceral Adipose Tissue Predictors and Women's Health: A Unicenter Study.

Authors:  Vanessa Carvalho Moreira; Calliandra Maria de Souza Silva; Izabel Cristina Rodrigues da Silva
Journal:  Int J Environ Res Public Health       Date:  2022-05-01       Impact factor: 4.614

5.  The impact and distinction of 'lipid healthy but obese' and 'lipid abnormal but not obese' phenotypes on lumbar disc degeneration in Chinese.

Authors:  Sheng Shi; Zhi Zhou; Jun-Jun Liao; Yue-Hua Yang; Jun-Song Wu; Shuang Zheng; Shi-Sheng He
Journal:  J Transl Med       Date:  2020-05-26       Impact factor: 5.531

6.  Association of genetic polymorphisms in SOD2, SOD3, GPX3, and GSTT1 with hypertriglyceridemia and low HDL-C level in subjects with high risk of coronary artery disease.

Authors:  Nisa Decharatchakul; Chatri Settasatian; Nongnuch Settasatian; Nantarat Komanasin; Upa Kukongviriyapan; Phongsak Intharaphet; Vichai Senthong
Journal:  PeerJ       Date:  2019-08-01       Impact factor: 2.984

7.  Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting.

Authors:  Roberto Scicali; Antonino Di Pino; Viviana Ferrara; Agata Maria Rabuazzo; Francesco Purrello; Salvatore Piro
Journal:  Acta Diabetol       Date:  2021-03-21       Impact factor: 4.280

8.  A 23-year study of mortality and development of co-morbidities in patients with obesity undergoing bariatric surgery (laparoscopic gastric banding) in comparison with medical treatment of obesity.

Authors:  Antonio E Pontiroli; Ahmed S Zakaria; Marco Fanchini; Chiara Osio; Elena Tagliabue; Giancarlo Micheletto; Alessandro Saibene; Franco Folli
Journal:  Cardiovasc Diabetol       Date:  2018-12-29       Impact factor: 9.951

9.  Plasma adiponectin, visfatin, leptin, and resistin levels and the onset of colonic polyps in patients with prediabetes.

Authors:  Lili Deng; Xiaotong Zhao; Mingwei Chen; Hua Ji; Qunhui Zhang; Ruofei Chen; Yalei Wang
Journal:  BMC Endocr Disord       Date:  2020-05-11       Impact factor: 2.763

10.  Analysis of Arterial Stiffness and Sexual Function after Adding on PCSK9 Inhibitor Treatment in Male Patients with Familial Hypercholesterolemia: A Single Lipid Center Real-World Experience.

Authors:  Roberto Scicali; Giorgio Ivan Russo; Marina Di Mauro; Flavia Manuele; Grazia Di Marco; Antonino Di Pino; Viviana Ferrara; Agata Maria Rabuazzo; Salvatore Piro; Giuseppe Morgia; Francesco Purrello
Journal:  J Clin Med       Date:  2020-11-08       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.